These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 11742250)

  • 21. Cluster C personality disorder has no independent effect on striatal dopamine transporter densities in major depression.
    Laasonen-Balk T; Viinamäki H; Kuikka J; Husso-Saastamoinen M; Lehtonen J; Halonen P; Tiihonen J
    Psychopharmacology (Berl); 2001 Apr; 155(1):113-4. PubMed ID: 11374331
    [No Abstract]   [Full Text] [Related]  

  • 22. Effect of MPTP-induced denervation on basal ganglia GABA(B) receptors: correlation with dopamine concentrations and dopamine transporter.
    Calon F; Lavertu N; Lemieux AM; Morissette M; Goulet M; Grondin R; Blanchet PJ; Bédard PJ; Di Paolo T
    Synapse; 2001 Jun; 40(3):225-34. PubMed ID: 11304760
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dopamine D2 receptor-deficient mice exhibit decreased dopamine transporter function but no changes in dopamine release in dorsal striatum.
    Dickinson SD; Sabeti J; Larson GA; Giardina K; Rubinstein M; Kelly MA; Grandy DK; Low MJ; Gerhardt GA; Zahniser NR
    J Neurochem; 1999 Jan; 72(1):148-56. PubMed ID: 9886065
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dopamine transport function is elevated in cocaine users.
    Mash DC; Pablo J; Ouyang Q; Hearn WL; Izenwasser S
    J Neurochem; 2002 Apr; 81(2):292-300. PubMed ID: 12064476
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Changes in dopamine availability in the nigrostriatal and mesocortical dopaminergic systems by gait in Parkinson's disease.
    Ouchi Y; Kanno T; Okada H; Yoshikawa E; Futatsubashi M; Nobezawa S; Torizuka T; Tanaka K
    Brain; 2001 Apr; 124(Pt 4):784-92. PubMed ID: 11287377
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Striatal dopamine transporter imaging correlates with anxiety and depression symptoms in Parkinson's disease.
    Weintraub D; Newberg AB; Cary MS; Siderowf AD; Moberg PJ; Kleiner-Fisman G; Duda JE; Stern MB; Mozley D; Katz IR
    J Nucl Med; 2005 Feb; 46(2):227-32. PubMed ID: 15695780
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lower midbrain dopamine transporter availability in depressed patients: Report from high-resolution PET imaging.
    Dubol M; Trichard C; Leroy C; Granger B; Tzavara ET; Martinot JL; Artiges E
    J Affect Disord; 2020 Feb; 262():273-277. PubMed ID: 31732277
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Regulation of rat dopamine transporter mRNA and protein by chronic cocaine administration.
    Letchworth SR; Sexton T; Childers SR; Vrana KE; Vaughan RA; Davies HM; Porrino LJ
    J Neurochem; 1999 Nov; 73(5):1982-9. PubMed ID: 10537056
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Self-administration of cocaine and the cocaine analog RTI-113: relationship to dopamine transporter occupancy determined by PET neuroimaging in rhesus monkeys.
    Wilcox KM; Lindsey KP; Votaw JR; Goodman MM; Martarello L; Carroll FI; Howell LL
    Synapse; 2002 Jan; 43(1):78-85. PubMed ID: 11746736
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Striatal dopamine, dopamine transporter, and vesicular monoamine transporter in chronic cocaine users.
    Wilson JM; Levey AI; Bergeron C; Kalasinsky K; Ang L; Peretti F; Adams VI; Smialek J; Anderson WR; Shannak K; Deck J; Niznik HB; Kish SJ
    Ann Neurol; 1996 Sep; 40(3):428-39. PubMed ID: 8797532
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Elevated striatal dopamine transporters during acute cocaine abstinence as measured by [123I] beta-CIT SPECT.
    Malison RT; Best SE; van Dyck CH; McCance EF; Wallace EA; Laruelle M; Baldwin RM; Seibyl JP; Price LH; Kosten TR; Innis RB
    Am J Psychiatry; 1998 Jun; 155(6):832-4. PubMed ID: 9619159
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dopamine transporter availability in symptomatic depressed patients with seasonal affective disorder and healthy controls.
    Neumeister A; Willeit M; Praschak-Rieder N; Asenbaum S; Stastny J; Hilger E; Pirker W; Konstantinidis A; Kasper S
    Psychol Med; 2001 Nov; 31(8):1467-73. PubMed ID: 11722161
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pinhole SPECT imaging of dopamine transporters correlates with dopamine transporter immunohistochemical analysis in the MPTP mouse model of Parkinson's disease.
    Andringa G; Drukarch B; Bol JG; de Bruin K; Sorman K; Habraken JB; Booij J
    Neuroimage; 2005 Jul; 26(4):1150-8. PubMed ID: 15908232
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The role of the striatal dopamine transporter in cognitive aging.
    Erixon-Lindroth N; Farde L; Wahlin TB; Sovago J; Halldin C; Bäckman L
    Psychiatry Res; 2005 Jan; 138(1):1-12. PubMed ID: 15708296
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Relationship between subjective effects of cocaine and dopamine transporter occupancy.
    Volkow ND; Wang GJ; Fischman MW; Foltin RW; Fowler JS; Abumrad NN; Vitkun S; Logan J; Gatley SJ; Pappas N; Hitzemann R; Shea CE
    Nature; 1997 Apr; 386(6627):827-30. PubMed ID: 9126740
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dose-response and duration effects of acute administrations of cocaine and GBR12909 on dopamine synthesis and transporter in the conscious monkey brain: PET studies combined with microdialysis.
    Tsukada H; Harada N; Nishiyama S; Ohba H; Kakiuchi T
    Brain Res; 2000 Mar; 860(1-2):141-8. PubMed ID: 10727633
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Brain dopamine transporter messenger RNA and binding sites in cocaine users: a postmortem study.
    Little KY; McLaughlin DP; Zhang L; McFinton PR; Dalack GW; Cook EH; Cassin BJ; Watson SJ
    Arch Gen Psychiatry; 1998 Sep; 55(9):793-9. PubMed ID: 9736005
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lack of dopamine receptor agonists effect on striatal dopamine transporter binding sites.
    Little KY; Gorebig J; Carroll FI; Mapili J; Meador-Woodruff JH
    Brain Res; 1996 Dec; 742(1-2):313-6. PubMed ID: 9117410
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Relationship between blockade of dopamine transporters by oral methylphenidate and the increases in extracellular dopamine: therapeutic implications.
    Volkow ND; Wang GJ; Fowler JS; Logan J; Franceschi D; Maynard L; Ding YS; Gatley SJ; Gifford A; Zhu W; Swanson JM
    Synapse; 2002 Mar; 43(3):181-7. PubMed ID: 11793423
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Characterization and localization of [125I]RTI-121 binding sites in human striatum and medial temporal lobe.
    Little KY; Carroll FI; Cassin BJ
    J Pharmacol Exp Ther; 1995 Sep; 274(3):1473-83. PubMed ID: 7562524
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.